0001209191-23-008685.txt : 20230213 0001209191-23-008685.hdr.sgml : 20230213 20230213160454 ACCESSION NUMBER: 0001209191-23-008685 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230209 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEIDENBERG BETH C CENTRAL INDEX KEY: 0001184592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 23618277 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-09 0 0001831828 Vera Therapeutics, Inc. VERA 0001184592 SEIDENBERG BETH C C/O VERA THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 1 0 0 0 Class A Common Stock 2023-02-09 4 P 0 400 7.25 A 1654630 I See footnote The shares were purchased as follows: 387 shares by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 13 shares by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein. Consists of 1,599,864 shares of Class A Common Stock held by KPCB XVI and 54,766 shares of Class A Common Stock held by XVI Founders. /s/ Joseph R. Young, Attorney-in-Fact 2023-02-13